While inhibition of this ATGL activity has been shown to alter breast tumor lung metastatic and neutrophil lipid profiles in mice models, it could be studied for NSCLC using high-throughput sequencing [34]. Here, PNPLA2 is linked to non-small cell lung carcinoma.